| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA204260
Max Phase: Preclinical
Molecular Formula: C16H13ClN6
Molecular Weight: 324.78
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: N=C(N)c1ccc2[nH]c(Cc3nc4cc(Cl)ccc4[nH]3)nc2c1
Standard InChI: InChI=1S/C16H13ClN6/c17-9-2-4-11-13(6-9)23-15(21-11)7-14-20-10-3-1-8(16(18)19)5-12(10)22-14/h1-6H,7H2,(H3,18,19)(H,20,22)(H,21,23)
Standard InChI Key: KMDMKWVPTMWHPW-UHFFFAOYSA-N
Associated Targets(Human)
Coagulation factor X 9693 Activities
Thrombin and coagulation factor X 145 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Coagulation factor VII and X 116 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 324.78 | Molecular Weight (Monoisotopic): 324.0890 | AlogP: 2.97 | #Rotatable Bonds: 3 |
| Polar Surface Area: 107.23 | Molecular Species: BASE | HBA: 3 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.44 | CX Basic pKa: 10.70 | CX LogP: 2.05 | CX LogD: 0.03 |
| Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.34 | Np Likeness Score: -1.07 |
References
| 1. Young WB, Sprengeler P, Shrader WD, Li Y, Rai R, Verner E, Jenkins T, Fatheree P, Kolesnikov A, Janc JW, Cregar L, Elrod K, Katz B.. (2006) Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation., 16 (3): [PMID:16257204] [10.1016/j.bmcl.2005.10.023] |
Source
Source(1):